Organochlorine compounds are released from body fat into the bloodstream during weight loss. Because these compounds may impair thyroid status, which is implicated in the control of resting metabolic rate (RMR), the aim of this study was to determine if the augmentation in plasma organochlorine concentrations might be associated with the decrease in serum T 3 concentration and RMR observed in response to body weight loss. Plasma organochlorine concentrations, serum T 3 concentration, and RMR were measured before and after weight loss in 16 obese men who followed a nonmacronutrient-specific energy-restricted diet for 15 weeks. As expected, a significant decrease in serum T 3 concentration and RMR was observed after the program, whereas concentrations of most detected organochlorines were significantly increased. Changes in organochlorine concentrations were negatively associated with changes in serum T 3 concentration (significantly for p,p-DDT, HCB, Aroclor 1260, PCB 28, PCB 99, PCB 118, and PCB 170) and with changes in RMR adjusted for weight loss (significantly for HCB and PCB 156). In conclusion, organochlorines released in plasma during weight loss are associated with the documented decrease in serum T 3 concentration and RMR. Further studies are needed to verify whether these findings are causally related.
Organochlorine compounds were widely used after the Second World War. They were cheap to produce and useful in many situations such as in agriculture as insecticides, in public health to control disease insect vectors, and in industries as heat transfer fluids and plasticizers. Although they initially did not seem to represent a health risk, some are now banned or restricted in many countries. All organochlorines are very resistant to degradation and accumulate in the food chain because they are lipophilic compounds. Thus, they are stored in fat of almost all living organisms, even the substances that are no longer in use nowadays. However, organochlorines can be released from adipose tissue during fat mobilization. The concentration of these compounds increases in plasma, adipose tissue, and various tissues as liver, heart, brain, or muscle after food restriction in animals previously fed diet containing organochlorines (Dale et al., 1962; Ecobichon and Saschenbrecker, 1969; Findlay and DeFreitas, 1971; Lakshmanan et al., 1979) . In humans, a study conducted in patients who underwent an intestinal bypass operation, which resulted in considerable body weight and fat losses, demonstrated that the concentration of dichlorodiphenyldichloroethane (DDE), the principal metabolite of dichlorodiphenyltrichloroethane (DDT), was increased in plasma and adipose tissue (Backman and Kolmodin-Hedman, 1978 ). An increase in plasma concentration of DDE and polychlorinated biphenyls (PCBs) during weight loss was also observed in two crew members of the Biosphere 2 (Walford et al., 1999) . Recently, a study in obese subjects showed an increase in plasma and adipose tissue concentrations of many organochlorine compounds after body weight loss (Chevrier et al., 2000) .
Organochlorines may have many adverse effects in animals and humans. Among these effects, the impairment of thyroid function has been reported. Indeed, evidence of goiters and diminution in plasma concentration of thyroid hormones were observed in Coho salmon (Oncorhynchus kisutch) (Barsano, 1981) and in rats (Barsano, 1981; Bastomsky, 1977; Byrne et al., 1987) exposed to PCBs. In humans, mothers displayed inverse correlations between PCB concentrations in the maternal milk and plasma level of triiodothyronine (T 3 ) and thyroxine (T 4 ). PCB concentrations in the maternal milk were inversely correlated to plasma T 4 level in their infants (Koopman-Esseboom et al., 1994) . Many mechanisms seem to be implicated in the diminution of thyroid hormones concentration by organochlorines. Collins et al. (1977) reported ultrastructural lesions in thyroid follicular cells of rats fed with PCBs, altering the synthesis and secretion of T 4 . Organochlorines compete for the receptor (Cheek et al., 1999) and for transport proteins of thyroid hormones (Bastomsky, 1974) . Moreover, organochlorines are microsomal enzyme inducers and can increase the catalytic activity toward T 4 of the hepatic enzyme uridine diphosphate-glucuronyltransferase (UDPGT), which is responsible for the glucuronidation of thyroid hor-mones. They increase the glucuronidation of T 4 and so its excretion in bile Klaassen, 1992, 1994; Bastomsky and Murthy, 1976; Van Birgelen et al., 1995) .
Serum concentration of thyroid hormones decreases during energy restriction (Danforth and Burger, 1984; Jung et al., 1980; Vagenakis et al., 1977; Wimpfheimer et al., 1979) . Thyroid hormones are implicated in the control of resting metabolic rate (RMR) (Danforth and Burger, 1984; Jéquier, 1984) . Energy expenditure decreases during body weight loss through a reduction of fat-free mass (FFM), fat mass (FM), insulin, sympathetic nervous system (SNS) activity, and leptin (Doucet et al., 2000; Van Gaal et al., 1992) . However, the contribution of all these factors does not explain the total reduction of energy expenditure in response to weight loss, suggesting that other factors might be involved. Recently, Rosenbaum et al. (2000) found a correlation between changes in thyroid hormone concentrations and energy expenditure in response to weight changes. Moreover, Toubro et al. (1996) reported that even small physiological differences in T 3 concentration are implicated in the variation of 24-h energy expenditure among humans. The main aim of this study was to determine if an increase in plasma concentration of organochlorines may affect serum T 3 concentration and RMR. However, the only ethical way (if any) to increase plasma organochlorine concentration in humans is weight loss, which is already known to decrease T 3 concentration and RMR by various factors. The residuals of changes in serum T 3 and RMR that were not explained by weight loss were associated with changes in plasma organochlorine concentrations to evaluate the potential effect of these compounds without the effect of changes in confounding variables.
MATERIALS AND METHODS
Subjects. Forty-six subjects gave their written consent to participate in this study, which received the approval of the Laval University Ethics Committee. From these 46 subjects, 16 obese men for whom plasma organochlorine concentrations, thyroid hormone concentrations, and RMR were measured are analyzed in this study. The subjects followed a nonmacronutrient-specific energy restricted diet for 15 weeks. First, daily energy expenditure (DEE) was calculated by multiplying RMR by an activity factor of 1.4. Prescribed daily energy intake was determined by subtracting 700 kcal from DEE. A 3-day dietary record was also used to estimate energy and macronutrient intake of each subject. To comply with diet, the subjects monitored their food intake with the food exchange system from the Québec Diabetes Association (1993), which was explained to each of them by a nutritionist. The subjects also came to the laboratory every 2 weeks to be weighed and asked about compliance. If a compliant subject had lost less than 1 kg during the last 2 weeks, the energy restriction was adjusted to ensure a progressive weight loss throughout the 15 weeks of the program. In addition to the diet, a medication (fenfluramine 60 mg/day) was used for 13 subjects, whereas the three others received a placebo. Medication compliance was also verified during the control visit, which also served to renew the subject's prescription when relevant.
It is important to note that following the withdrawal of fenfluramine and dexfenfluramine from the market because of their effects on myocardial valve function (Khan et al., 1998; Weissman et al., 1998) , all subjects (including placebos) were subjected to an echocardiogram. Following this measure, a detailed analysis of valve function was performed by cardiologists who detected no abnormalities in response to the use of fenfluramine under these conditions (Prud'homme et al., 1999) .
RMR and anthropometric measurements. RMR was determined by indirect calorimetry after an overnight fast. Following a 15-min resting period, expired gases were collected through a mouthpiece for 15 min while the subject had his nose clipped. A nondispersive infrared analyzer (Uras 10 E, Hartmann & Braun, Frankfurt, Germany) was used to measure the oxygen and carbon dioxide concentrations. The pulmonary ventilation was determined with an S-430A measurement system (Ventura, CA). The energy equivalent of oxygen volume was calculated by the Weir formula (Weir, 1949) .
Body density was measured by the hydrostatic weighing technique, and the Siri equation (Siri, 1956 ) was used to determine the percentage of body fat. The pulmonary residual volume required for this measurement was determined by the helium dilution technique (Meneely and Kaltreider, 1949) . The percentage of body fat was multiplied with body weight to calculate total fat mass, which was subtracted from body weight to obtain fat-free mass. All measurements were performed before and after weight loss.
Determination of plasma organochlorine concentrations. The concentration of 11 chlorinated pesticides and metabolites (␤-hexachlorocyclohexane (␤-HCH), p,pЈ-DDT, p,pЈ-DDE, hexachlorobenzene (HCB), mirex, aldrin, ␣-chlordane, ␥-chlordane, oxychlordane, cis-nonachlor, trans-nonachlor), 14 PCBs (IUPAC nos. 28, 52, 99, 101, 105, 118, 128, 138, 153, 156, 170, 180, 183, and 187) and one commercial mixture of PCBs (Aroclor 1260) were determined in plasma before and after weight loss at the Québec Toxicology Center. Blood samples were centrifuged to extract plasma (2 ml), which was cleaned up on deactivated Florisil columns. Samples were eluted with methylene chloride:hexane (25:75, v/v) and concentrated to a final volume of 100 l. Samples were then analyzed on an HP-5890 series II gas chromatograph with dual-capillary columns and dual 63 Ni electron detectors. Peaks were identified by their relative retention times obtained on the two columns using a computer program developed by the Québec Toxicology Center. Depending on the compounds, detection limits varied from 0.02 to 0.2 g/l. Plasma lipid concentration was also determined. This measurement was performed by enzymatic methods on a Technicon automatic analyzer (RA-500) with test packs: Randox for total cholesterol (TC) and triglycerides (TG), BMC for free cholesterol (FC), and Wako for phospholipids (PL). Plasma total lipids were calculated with the equation recommended by Patterson et al. (1991) :
The concentrations of organochlorines are expressed in micrograms per kilogram of lipids.
Plasma leptin, serum total T 3 and free T 4 concentrations. Fasting plasma leptin concentrations were determined with a highly sensitive commercial double antibody RIA (Human Leptin Specific RIA Kit, Linco Research, Inc., St. Louis, MO), which has a low detection limit of 0.5 ng/ml and does not cross-react with human insulin, pro-insulin, glucagon, pancreatic polypeptide, or somatostatin. Serum total T 3 and free T 4 concentrations were determined by heterogeneous competitive immunoassay (Bayer Immuno 1™ System, Bayer Corporation, Tarrytown, NY). Detection limits were 0.09 nmol/l and 1.3 pmol/l for total T 3 and free T 4 , respectively.
Statistical analysis. The deltas were equal to the values post-weight loss minus pre-weight loss. A two-way ANOVA for repeated measures was used to evaluate the impact of time, treatment (fenfluramine or placebo) and their interaction on weight, BMI, fat mass, fat-free mass, RMR, leptin, total T 3 , free T 4 and organochlorine concentrations. Pearson correlation coefficients were calculated to measure the associations between changes in plasma organochlorine concentrations and those in T 3 concentration and in RMR, not adjusted and adjusted for body weight loss, during the weight-reducing program. Pearson correlation coefficient was also calculated between changes in T 3 concentration and those in RMR during weight loss. As many factors are known to affect RMR, a stepwise multiple regression analysis was used to determine which factors contribute to variation in RMR before, during, and after weight loss. Results are presented as means Ϯ standard deviation and were considered statistically significant at p Յ 0.05.
RESULTS
A significant effect of time was observed for weight, BMI, fat mass, fat-free mass, RMR, leptin, and total T 3 in response to the weight-reducing program (Table 1) . No effects of the treatment (fenfluramine vs. placebo) or treatment ϫ time interaction were observed, except for free T 4 , for which a treatment ϫ time interaction was noted. The average weight loss was 10.7 kg (p Ͻ 0.001), which was attributable mainly to fat loss (-9.3 kg, p Ͻ 0.001). RMR decreased during weight loss (Table 1 ). This decrease in RMR (-13%, p Ͻ 0.001) was significantly correlated with body weight loss (r ϭ 0.53, p Ͻ 0.05), whereas no correlation was found between changes in fat-free mass and those in RMR (r ϭ -0.10, NS). Leptin and total T 3 concentrations also decreased during the weight loss program (-39%, p Ͻ 0.001 and -7%, p Ͻ 0.05, respectively). No change in free T 4 concentration was observed.
Seventeen organochlorines were measured in plasma. The increase in plasma concentration of organochlorines during weight loss was significant for 13 (Table 2) . Changes in plasma organochlorine concentrations tended to be negatively associated with changes in serum T 3 concentration, the correlations being significant for seven of the compounds measured (Table  3) . This trend for negative associations persisted after adjust- ment for weight loss, the correlations remaining significant for PCB 28, 99, 118, and 170 (Table 3) . Changes in organochlorines were also correlated with the changes in RMR. The negative correlations obtained were significant for p,pЈ-DDT (r ϭ -0.51, p ϭ 0.043), HCB (r ϭ -0.64, p ϭ 0.007), Aroclor 1260 (r ϭ -0.52, p ϭ 0.039), PCB 153 (r ϭ -0.53, p ϭ 0.035) and PCB 156 (r ϭ -0.53, p ϭ 0.037), although all other correlations also showed a trend toward negative associations (r ranging between -0.12 and -0.48). To verify if these correlations were explained by the body weight loss-related decrease in RMR, changes in RMR were correlated with changes in body weight and the residuals were then correlated with the organochlorines. As shown in Figure 1 , the negative correlations remained significant for HCB and PCB 156 after this adjustment. No significant correlation was obtained between changes in T 3 concentration and those in RMR (r ϭ 0.24, NS).
A stepwise multiple regression analysis was performed to determine which factors were the best predictors of RMR before, during, and after weight loss (Table 4 ). The covariates entered in the model were fat mass, fat-free mass, leptin concentration, T 3 concentration, and total organochlorine concentration (being the sum of all compound concentrations). Before weight loss, the variance of RMR was mostly predicted by FFM (38%, p ϭ 0.003), and T 3 concentration explained another 27% (p ϭ 0.008). However, during the weight loss program, changes in total organochlorine concentration were the best predictor of changes in RMR, explaining 32% (p ϭ 0.02) of its variance. After weight loss, FM was the only significant predictor of the variance of RMR (27%, p ϭ 0.04).
DISCUSSION
The main finding of this study was that organochlorines released into the blood during body weight loss are associated with the decrease in serum T 3 concentration and RMR. Asso- Note. Variables entered in the model: dependent variable, RMR; predicting variables, FM, FFM, leptin, T 3 , total organochlorines (being the sum of all measured compounds). Pre, pre-weight loss; post, post-weight loss.
ciations between a higher exposure to PCBs and a lower T 3 concentration have been reported for many species, including man (Barsano, 1981; Bastomsky, 1977; Byrne et al., 1987; Koopman-Esseboom et al., 1994) , but never in a context of weight loss. However, T 3 concentration decreases during energy restriction (Danforth and Burger, 1984; Jung et al., 1980; Vagenakis et al., 1977; Wimpfheimer et al., 1979) . In the present study, we have shown that a greater increase in organochlorine concentrations was associated to a greater decrease in T 3 concentration in response to weight loss.
The increase in organochlorine concentrations was also associated with the decrease in RMR during weight loss. Thyroid hormones are implicated in the control of energy expenditure, which agrees with our observation that serum T 3 concentration explained a significant portion of the variance in RMR in weight-stable obese men before the weight loss program. However, during the weight-reducing program, changes in T 3 concentration and those in RMR were not significantly correlated. This is consistent with the results of Rosenbaum et al. (2000) , who found a significant correlation between these two variables only when they pooled the data from subjects who gained weight (increasing their T 3 concentration and RMR) and those from subjects who lost weight (decreasing their T 3 concentration and RMR). In the present study, the absence of association between changes in T 3 concentration and those in RMR was predictable, as T 3 did not contribute to the variation of RMR after weight loss. It has been reported by Wimpfheimer et al. (1979) that the sensitivity of RMR to T 3 was reduced by starvation. Furthermore, beyond the reduction in T 3 concentration, fasting also decreases the capacity of the nuclear T 3 receptors to bind the hormone (Schussler and Orlando, 1978) . These two findings could provide an explanation for the absence of relation between T 3 concentration and RMR after weight loss. In spite of the absence of association between changes in T 3 concentration and those in RMR, changes in plasma organochlorine concentrations were the best predictor of changes in RMR observed during weight loss. Changes in organochlorine concentrations explained a greater part of the variation in RMR than other factors known to affect RMR during weight loss, such as body composition and plasma leptin. This is not discordant with the results of Doucet et al. (2000) , who documented in these subjects that changes in leptin were an important predictor of changes in RMR in response to weight loss. However, the percentage of variation in RMR during weight loss explained by leptin in the study by Doucet et al. (2000) (28%) was lower than the percentage of variation in RMR explained by changes in organochlorine concentrations in the present study (32%).
The clinical significance of the association between changes in plasma organochlorine concentrations and changes in RMR is as yet unknown. The release of these compounds from body fat to bloodstream could be associated with the weight regain which more often than not occurs after weight loss (Weinsier et al., 1995) . Previous studies in animals a priori fed with contaminated food and then put on starvation demonstrated that organochlorines redistributed in many tissues after weight loss may exert their adverse effects (Bigsby et al., 1997; Dale et al., 1962; Ecobichon and Saschenbrecker, 1969) . As proposed by Chevrier et al. (2000) and Tremblay et al. (1999) , body fat accumulation can be a means of protection against the adverse effects of organochlorines. Although speculative, the weight-loss-induced increase in organochlorine concentrations might facilitate positive energy balance through a decrease in RMR and consequently promote body fat accumulation. As a result of the high affinity of organochlorines for adipose tissue, body fat accumulation would increase the storage compartment of these compounds, keeping them away from their target organs. However, toxicity of the concentration of organochlorines released from fat stores during weight loss can not yet be assessed. Because weight loss reduces risks of cardiovascular diseases, diabetes, and hypertension, known benefits of weight loss treatments are still considered as greater than possible health risks that would be due to organochlorines in the reduced-obese state. However, even if not representing health risks, small physiological effects of organochlorines such as the relationships observed in this study could complicate weight loss treatment, and thus favor a smaller body weight loss or weight regain.
An evident limitation of this study is that the increase in plasma organochlorine concentration was promoted by weight loss. Many factors such as fat mass, fat-free mass, and leptin concentration are also changing during weight loss and are known to decrease serum T 3 concentration and RMR. Precautions were taken in this analysis to eliminate the effect of body weight loss on serum T 3 concentration and RMR. However, it is still possible that confounding variables may explain a part of the relationships observed in this study. The small sample size is another limitation of this study. The correlations obtained give preliminary results that suggest the existence of a relationship between changes in organochlorine compound concentrations, serum T 3 concentration, and RMR that are promoted by weight loss. However, further studies are needed to verify whether these observations are causally related and to investigate the mechanisms by which organochlorines may affect RMR. Apart from the decrease in serum T 3 concentration, organochlorines may also interfere with T 3 receptor and thus alter RMR. The results of the present study also suggest that the release of organochlorines from body fat during weight loss should be considered when treating obesity.
